Compare HTCR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | BGLC |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | Japan | Malaysia |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 4.4M |
| IPO Year | 2022 | 2019 |
| Metric | HTCR | BGLC |
|---|---|---|
| Price | $2.65 | $1.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 27.8K | 10.3K |
| Earning Date | 05-14-2026 | 04-14-2026 |
| Dividend Yield | ★ 87.84% | N/A |
| EPS Growth | ★ 414.29 | 45.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,407,229.00 | $7,424,911.00 |
| Revenue This Year | $123.26 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.19 | N/A |
| 52 Week Low | $0.15 | $1.07 |
| 52 Week High | $3.97 | $6.10 |
| Indicator | HTCR | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 52.29 | 48.96 |
| Support Level | $2.43 | $1.55 |
| Resistance Level | $2.91 | $2.15 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 62.05 | 32.14 |
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.